Sigma Metric Analysis
Continuing in our series of CLIA 2025 check-ups, we take a look at an example cobas 8000 series in France. If this laboratory was in the US, would they be able to meet new CLIA targets?
Continuing in our series of CLIA 2025 check-ups, we take a look at an example cobas e801 in the US. Can these IA assays hit the new goals?
Continuing in our series of CLIA 2025 check-ups, we take a look at an example Vitros XT 7600 in the US. Is IA on the dry side better suited for the new goals?
Continuing in our series of CLIA 2025 check-ups, we take a look at an example Alinity in the US. IA assays have harder goals to hit come January 1st. Will the new year bring joy, or sorrow?
Continuing in our series of CLIA 2025 check-ups, we take a look at an example Atellica in the US. Can it pass the new goals for CLIA? Or is January 1st going to be the start of an agonizing year?